Hospital
Columbia Lutheran Charities
Columbia Lutheran Charities was paid $21.46M by Medicaid between Jan 2018 and Dec 2024, across 97 billing codes. Its largest line is 99284, emergency room visit (serious) — 37% of everything it billed.
33Billing provider infoCOLUMBIA LUTHERAN CHARITIES
ASTORIA, OR 97103
ASTORIA, OR 97103
33aNPI1134146939assigned 07/16/2006
33bProvider typeCritical Access Hospital
28Total paid$21.46M
24GClaims177,056
24DCodes billed97
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Oregon
Rank by total paid#3 of 22
Median peer was paid$3.52M
This provider vs. median6.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,304 | $2.48M | |
| 2019 | 25,546 | $2.77M | |
| 2020 | 21,457 | $2.60M | |
| 2021 | 23,547 | $2.44M | |
| 2022 | 29,415 | $3.23M | |
| 2023 | 30,553 | $3.72M | |
| 2024incomplete | 25,234 | $4.24M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 37% | 27,438 | 19,267 | $8.04M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 18,794 | 14,352 | $4.54M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 7,928 | 5,050 | $3.60M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.4% | 11,407 | 8,016 | $1.37M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.7% | 7,275 | 5,941 | $587K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.5% | 21,351 | 17,073 | $527K |
| 80053 | Comprehensive metabolic panel | 2.0% | 15,693 | 12,935 | $432K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.9% | 2,006 | 1,032 | $401K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.2% | 4,654 | 3,942 | $254K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,893 | 639 | $173K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,716 | 1,409 | $140K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 2,267 | 1,665 | $130K |
85 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 14,649 | $121K |
| 73630 | <1% | 1,384 | $111K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,227 | $74K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,418 | $69K |
| 83605 | <1% | 1,749 | $59K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 71 | $50K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 389 | $50K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,472 | $48K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 769 | $42K |
| 84484 | <1% | 1,331 | $41K | |
| 81003 | <1% | 3,932 | $41K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 4,227 | $41K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 803 | $40K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 285 | $39K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 517 | $33K |
| 80061 | Lipid panel | <1% | 1,108 | $32K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 321 | $30K |
| 83690 | <1% | 1,329 | $29K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,484 | $28K |
| 83735 | <1% | 1,481 | $27K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 87 | $20K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 618 | $19K |
| 85027 | <1% | 1,468 | $18K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 172 | $17K |
| 81001 | <1% | 1,260 | $16K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 331 | $15K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 331 | $13K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 368 | $12K |
| 81025 | <1% | 583 | $12K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,363 | $11K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 607 | $10K |
| 87631 | <1% | 43 | $8K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 27 | $8K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 443 | $8K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 527 | $7K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 45 | $7K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 611 | $6K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 99 | $6K |
| 73610 | <1% | 49 | $5K | |
| 87186 | <1% | 186 | $4K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 27 | $4K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 792 | $4K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 287 | $3K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 35 | $3K |
| 87077 | <1% | 126 | $3K | |
| 82728 | <1% | 63 | $3K | |
| 59025 | Fetal non-stress test | <1% | 31 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 187 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 12 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 59 | $2K |
| 86902 | <1% | 31 | $2K | |
| 87070 | <1% | 81 | $2K | |
| 83880 | <1% | 100 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 41 | $2K |
| 83550 | <1% | 38 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 70 | $1K |
| 83540 | <1% | 38 | $1K | |
| 86780 | <1% | 83 | $1K | |
| 84439 | <1% | 55 | $1K | |
| 82607 | <1% | 43 | $925.12 | |
| 85610 | <1% | 131 | $923.03 | |
| 86901 | <1% | 57 | $694.73 | |
| 86900 | <1% | 57 | $688.47 | |
| 73030 | <1% | 15 | $686.03 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 15 | $667.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 19 | $644.30 |
| 84550 | <1% | 36 | $622.48 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 57 | $590.84 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 47 | $586.15 |
| 86703 | <1% | 14 | $548.90 | |
| 87899 | <1% | 14 | $540.41 | |
| 94664 | <1% | 13 | $526.96 | |
| 84145 | <1% | 17 | $481.25 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 28 | $477.19 |
| 80306 | <1% | 20 | $470.40 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 14 | $351.45 |
| 80321 | <1% | 27 | $345.60 | |
| J2704 | Injection, propofol, 10 mg | <1% | 15 | $301.27 |
| 86140 | <1% | 14 | $281.55 | |
| 85730 | <1% | 19 | $260.36 | |
| J3490 | Unclassified drugs | <1% | 27 | $214.05 |
| 85651 | <1% | 14 | $198.40 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 83 | $2.24 |
| 0353U | 0% | 42 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 476 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHORSEN, ERIK (CEO)
| Provider | Location | Paid |
|---|---|---|
| Columbia Lutheran Charities | Astoria, OR | $4.69M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.